Volume 137, Issue 4, Pages (October 2009)

Slides:



Advertisements
Similar presentations
Volume 137, Issue 4, Pages (October 2009)
Advertisements

Volume 145, Issue 4, Pages (October 2013)
Volume 138, Issue 1, Pages (January 2010)
Functions and Imaging of Mast Cell and Neural Axis of the Gut
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Volume 132, Issue 1, Pages (January 2007)
Activity of Protease-Activated Receptors in the Human Submucous Plexus
Volume 136, Issue 3, Pages (March 2009)
Volume 148, Issue 5, Pages e4 (May 2015)
Activity of Protease-Activated Receptors in the Human Submucous Plexus
Volume 131, Issue 4, Pages (October 2006)
Christoph Lübbert, Babett Holler  Gastroenterology 
Covering the Cover Gastroenterology
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
A Pilot Study of Fecal Serine-Protease Activity: A Pathophysiologic Factor in Diarrhea- Predominant Irritable Bowel Syndrome  Richárd Róka, András Rosztóczy,
This Month in Gastroenterology
Role of Colonic Fermentation in the Perception of Colonic Distention in Irritable Bowel Syndrome and Functional Bloating  Michele Di Stefano, Emanuela.
Glial Cell–Derived Neurotrophic Factor Enhances Synaptic Communication and 5- Hydroxytryptamine 3a Receptor Expression in Enteric Neurons  Fanning Zeng,
Volume 132, Issue 1, Pages (January 2007)
Volume 141, Issue 5, Pages (November 2011)
Involvement of TRPV4 in Serotonin-Evoked Scratching
Volume 146, Issue 2, Pages e1 (February 2014)
Volume 130, Issue 5, Pages (April 2006)
Volume 154, Issue 5, Pages (April 2018)
Volume 132, Issue 1, Pages (January 2007)
Volume 133, Issue 3, Pages (September 2007)
Volume 155, Issue 4, Pages (October 2018)
Volume 135, Issue 4, Pages (October 2008)
Volume 150, Issue 4, Pages (April 2016)
Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles  Michael Camilleri, Lin Chang  Gastroenterology 
Volume 137, Issue 3, Pages (September 2009)
Pyloric Sphincter Dysfunction in nNOS−/− and W/Wv Mutant Mice: Animal Models of Gastroparesis and Duodenogastric Reflux  Digavalli V. Sivarao, Hiroshi.
Volume 133, Issue 1, Pages (July 2007)
Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic.
Volume 155, Issue 6, Pages (December 2018)
Volume 128, Issue 5, Pages (May 2005)
Purinergic Neuron-to-Glia Signaling in the Enteric Nervous System
Volume 147, Issue 6, Pages e5 (December 2014)
Volume 68, Issue 5, Pages (December 2010)
Efficient Early Drug Development for Ulcerative Colitis
Volume 129, Issue 5, Pages (November 2005)
Volume 153, Issue 4, Pages (October 2017)
Kara Bradford, Wendy Shih, Elizabeth J. Videlock, Angela P
Coffee and Colorectal Cancer: Grounds for Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Targeting Enteric Neuroplasticity: Diet and Bugs as New Key Factors
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Rebecca M. Lovell, Alexander C. Ford 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
An Unusual Cause of Small Bowel Obstruction
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Immune Activation in Patients With Irritable Bowel Syndrome
The Dawning of a New Editorial Board for Gastroenterology
Volume 151, Issue 4, Pages (October 2016)
Dendritically Released Peptides Act as Retrograde Modulators of Afferent Excitation in the Supraoptic Nucleus In Vitro  Samuel B Kombian, Didier Mouginot,
Volume 131, Issue 2, Pages (August 2006)
Volume 58, Issue 1, Pages (April 2008)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 131, Issue 5, Pages (November 2006)
Reinvesting in US Biomedical Research—The Time is Now
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
Volume 133, Issue 4, Pages (October 2007)
Electronic Clinical Challenges and Images in GI
Volume 139, Issue 1, Pages (July 2010)
Controversies in Liver Transplantation for Hepatitis C
Bowel Urgency in Patients With Irritable Bowel Syndrome
Covering the Cover Gastroenterology
An Unusual Cause of Life-Threatening Upper Gastrointestinal Bleeding
Presentation transcript:

Volume 137, Issue 4, Pages 1425-1434 (October 2009) Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome  Sabine Buhner, Qin Li, Sheila Vignali, Giovanni Barbara, Roberto De Giorgio, Vincenzo Stanghellini, Cesare Cremon, Florian Zeller, Rupert Langer, Hannelore Daniel, Klaus Michel, Michael Schemann  Gastroenterology  Volume 137, Issue 4, Pages 1425-1434 (October 2009) DOI: 10.1053/j.gastro.2009.07.005 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 IBS but not HC supernatants evoked action potential discharge in human submucosal plexus neurons. (A) Di-8-ANEPPS labeled ganglion revealing outline of dye labeled individual neurons. Signals from 2 of the neurons are shown in traces A-1 and A-2. Application of supernatants was 200 ms (indicated by bars below the traces). Neuron A-1 did not respond to application of HC supernatant. In contrast, D-IBS 23 supernatant evoked discharge of action potentials. Neuron A-2 did not respond to HC or IBS supernatants. Panel B shows representative traces to illustrate the similarity of the responses to D-IBS (middle trace) and C-IBS supernatants (bottom trace). The number of action potentials (AP) in the particular trace is given in the right upper corner. Gastroenterology 2009 137, 1425-1434DOI: (10.1053/j.gastro.2009.07.005) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Compared with HC, each of the IBS supernatants significantly increased spike discharge in 40%–100% of the neurons per ganglion. Data for HC supernatants were pooled. Proportions of activated neurons are given as median percentage (25th and 75th percentiles); (T/G/N): number of tissues/ganglia/neurons; *P < .05 compared with HC. Gastroenterology 2009 137, 1425-1434DOI: (10.1053/j.gastro.2009.07.005) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Serotonin receptor (5-HT3), histamine receptor (H1, H2, H3) blockade, and protease inhibition inhibited IBS supernatant-evoked spike discharge. Panels A–C show neuron responses after control application IBS supernatant, reapplication with blockers, and after washout of blockers. (A) IBS supernatant-evoked spike discharge is reduced by the 5-HT3 receptor antagonist cilansetron and recovers after 40-minute washout. (B) IBS supernatant evoked spike discharge is reduced by the combined application of the H1, H2, and H3 antagonists ranitidine, pyrilamine, and clobenpropit, respectively. (C) Preincubation of the IBS supernatant with the protease inhibitor FUT-175 blocked the spike discharge. A second application of the IBS supernatant still evoked a response. The number of action potentials (AP) in the particular trace is given in the right upper corner. Gastroenterology 2009 137, 1425-1434DOI: (10.1053/j.gastro.2009.07.005) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 (A) Tryptase and histamine but not serotonin concentrations were significantly higher in IBS supernatants compared with supernatants from HC; crosses next to dot plots indicate medians and interquartile ranges (25th and 75th percentiles). (B) Tryptase, histamine, and serotonin concentrations in the supernatants significantly correlated with the supernatant-evoked action potential discharges. Gastroenterology 2009 137, 1425-1434DOI: (10.1053/j.gastro.2009.07.005) Copyright © 2009 AGA Institute Terms and Conditions